Overview

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-30
Target enrollment:
Participant gender:
Summary
Phase II Clinical Study of Adebrelimab Combined with Apatinib and Paclitaxel for Injection(Albumin Bound) as Second-line Therapy in Patients with Advanced Gastric Cancer Previously Treated with Immunotherapy
Phase:
PHASE2
Details
Lead Sponsor:
Chinese PLA General Hospital